Literature DB >> 1721282

The pharmacodynamics of pentobarbital following FK 506 therapy.

K Habucky1, R Venkataramanan, R Xiaoshan, V S Warty, J J Fung, T E Starzl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1721282      PMCID： PMC2981164     

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  5 in total

1.  FK 506 inhibition of cyclosporine metabolism by human liver microsomes.

Authors:  G Omar; I A Shah; A W Thomson; P H Whiting; M D Burke
Journal:  Transplant Proc       Date:  1991-02       Impact factor: 1.066

2.  Biopharmaceutical aspects of FK-506.

Authors:  R Venkataramanan; V S Warty; M A Zemaitis; A T Sanghvi; G J Burckart; H Seltman; S Todo; L Makowka; T E Starzl
Journal:  Transplant Proc       Date:  1987-10       Impact factor: 1.066

3.  A highly sensitive method to assay FK-506 levels in plasma.

Authors:  K Tamura; M Kobayashi; K Hashimoto; K Kojima; K Nagase; K Iwasaki; T Kaizu; H Tanaka; M Niwa
Journal:  Transplant Proc       Date:  1987-10       Impact factor: 1.066

4.  Metabolism of drugs in old rats. II. Metabolism in vivo and effect of drugs in old rats.

Authors:  R Kato; A Takanaka
Journal:  Jpn J Pharmacol       Date:  1968-12

5.  A simple and rapid high-pressure liquid chromatographic assay for pentobarbital and other barbiturates in serum.

Authors:  A Alila; J E Heavner; P H Rosenberg
Journal:  Am J Vet Res       Date:  1988-05       Impact factor: 1.156
  5 in total
  1 in total

Review 1.  Clinical pharmacokinetics of tacrolimus.

Authors:  R Venkataramanan; A Swaminathan; T Prasad; A Jain; S Zuckerman; V Warty; J McMichael; J Lever; G Burckart; T Starzl
Journal:  Clin Pharmacokinet       Date:  1995-12       Impact factor: 6.447
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.